poisar

Stock

Journey Medical Corporation DERM

$6.52-1.95%

Overview

DERM market data

Price History

DERM price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.47
Diluted earnings per share over the trailing twelve months.
Beta
1.06
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-14.8%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$4.31 – $9.56
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $183.1M · P/B 6.57 · P/S 2.83.

Company News

3 captured
B. Riley Securities Reiterates Buy on Journey Medical, Raises Price Target to $15Benzinga · Aug 13, 2026, 1:15 PM
Journey Medical Q2 EPS $(0.01) Beats $(0.02) Estimate, Sales $17.839M Miss $18.366M EstimateBenzinga · Aug 12, 2026, 8:02 PM
Journey Medical shares are trading higher after the company reported better-than-expected Q1 sales results.Benzinga · May 14, 2026, 4:02 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock